The China Securities Association announces the list of on-site inspections for the fourth batch of IPOs in 2026, with 11 companies on the list planning to IPO on the Science and Technology Innovation Board.

The CSRC announced today the on-site inspection sampling list of the fourth batch of issuers in 2026, with a total of 21 IPOs selected for inspection. Among them, 11 IPOs are from the sci-tech innovation board, including Shewhe Genomics, Borui Kang, Pusen Medical, Zuo Lei Laser, Haoda Electronics, Xiahe Technology, Wukewei, Jinlian Technology, China Electronic Defense, Huihe Medical, and Dongfang Jingyuan; 8 IPOs are from the ChiNext board, including Guanghai New Materials, Naidi shares, Superpower Electric, Yadong Zhongke, Bailing Bio, Ruigao New Materials, Yongkang Defense, and Yike Gas; 2 IPOs are from the main board of the Shanghai Stock Exchange, namely Shenghuabo and Kangbaijia. It is worth noting that all 21 IPOs selected for on-site inspection in this round were accepted in June.